IBD (Inspire Corporate Bond ETF) Stock Analysis - Insider Trades

Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading IBD stock inside the company?

Rallies tracks IBD insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

IBD Key Metrics

Key financial metrics for IBD
MetricValue
Price$23.80
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume139.86K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBD News

IBD Analyst Consensus

IBD analyst coverage data. Average price target: $0.00.

Common questions about IBD

Who is trading IBD stock inside the company?
Rallies tracks IBD insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for IBD?
Yes. Rallies tracks IBD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IBD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBD. It does not provide personalized investment advice.
IBD

IBD